We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Par Wants Bulk Vasopressin Compounding Nixed; FDA Agrees

Law360 (August 27, 2018, 10:21 PM EDT) -- Just as Par Pharmaceutical asked a D.C. federal court Monday to enjoin a U.S. Food and Drug Administration policy governing bulk drug compounding, the agency agreed the same day that the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.